EyePoint Pharmaceuticals Inc (EYPT)
12.06
+0.30
(+2.55%)
USD |
NASDAQ |
Nov 01, 16:00
12.07
+0.01
(+0.08%)
After-Hours: 20:00
EyePoint Pharmaceuticals Price to Book Value: 2.827 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.827 |
| October 31, 2024 | 2.757 |
| October 30, 2024 | 2.686 |
| October 29, 2024 | 2.705 |
| October 28, 2024 | 2.841 |
| October 25, 2024 | 2.227 |
| October 24, 2024 | 2.241 |
| October 23, 2024 | 2.335 |
| October 22, 2024 | 2.52 |
| October 21, 2024 | 2.508 |
| October 18, 2024 | 2.590 |
| October 17, 2024 | 2.614 |
| October 16, 2024 | 2.644 |
| October 15, 2024 | 2.316 |
| October 14, 2024 | 2.384 |
| October 11, 2024 | 2.070 |
| October 10, 2024 | 1.932 |
| October 09, 2024 | 1.967 |
| October 08, 2024 | 1.988 |
| October 07, 2024 | 2.042 |
| October 04, 2024 | 2.023 |
| October 03, 2024 | 1.962 |
| October 02, 2024 | 1.925 |
| October 01, 2024 | 1.875 |
| September 30, 2024 | 1.873 |
| Date | Value |
|---|---|
| September 27, 2024 | 1.871 |
| September 26, 2024 | 1.892 |
| September 25, 2024 | 1.910 |
| September 24, 2024 | 1.955 |
| September 23, 2024 | 1.943 |
| September 20, 2024 | 2.089 |
| September 19, 2024 | 2.152 |
| September 18, 2024 | 2.089 |
| September 17, 2024 | 2.058 |
| September 16, 2024 | 2.072 |
| September 13, 2024 | 2.133 |
| September 12, 2024 | 2.082 |
| September 11, 2024 | 1.927 |
| September 10, 2024 | 1.882 |
| September 09, 2024 | 1.932 |
| September 06, 2024 | 1.868 |
| September 05, 2024 | 1.889 |
| September 04, 2024 | 1.960 |
| September 03, 2024 | 1.912 |
| August 30, 2024 | 2.098 |
| August 29, 2024 | 2.044 |
| August 28, 2024 | 2.068 |
| August 27, 2024 | 2.131 |
| August 26, 2024 | 2.180 |
| August 23, 2024 | 2.154 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5924
Minimum
Dec 19 2022
26.93
Maximum
Jan 28 2020
6.072
Average
3.353
Median
Price to Book Value Benchmarks
| Cassava Sciences Inc | 6.654 |
| Adverum Biotechnologies Inc | 0.9173 |
| Regenxbio Inc | 1.247 |
| Editas Medicine Inc | 1.034 |
| Apellis Pharmaceuticals Inc | 12.89 |
Price to Book Value Related Metrics
| PS Ratio | 11.17 |
| Price | 12.06 |
| Earnings Yield | -14.76% |
| Market Cap | 645.43M |